Portosystemic Encephalopathy: Clinical Trials

1 trial for Portosystemic Encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Portosystemic Encephalopathy: new trials by email Literature Review of Portosystemic Encephalopathy trials Research Report on Portosystemic Encephalopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
Polyethylene glycol 3350-electrolyte solution (GoLYTELY®), Lactulose - Hepatic Encephalopathy, Cirrhosis
Not applicableCompletedUniversity of Texas Southwestern Medical Center502011-01-012014-12-11

Narrower conditions

Fibrosis (1)  ·  Hepatic Encephalopathy (1)

Broader conditions

Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Central Nervous System Diseases (1)  ·  Digestive System Diseases (1)  ·  Hepatic Insufficiency (1)  ·  Liver Diseases (1)  ·  Liver Failure (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Golytely (1)  ·  Lactulose (1)  ·  polyethylene glycol 3350 (1)

Sponsors

University of Texas Southwestern Medical Center (1)

Countries

United States (1)

Top investigators

Robert S Rahimi, MD, MSCR (1)

Results publications

PMID 25243839